SNWV
SANUWAVE Health Inc. (SNWV) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
Interest coverage of 0.19x suggests limited earnings buffer, leaving SNWV more exposed than peers if rates stay elevated or demand softens.
Days inventory outstanding of 237 and a 174-day cash conversion cycle imply working-capital drag, which can constrain liquidity versus faster-turning peers.
Current ratio of 1.28 and quick ratio of 0.89 indicate only modest short-term liquidity, reducing flexibility relative to stronger-balance-sheet competitors.
Debt-to-equity of 7.43x signals a highly levered capital structure, so refinancing or covenant pressure could weigh on realized outcomes more than for peers.
Opportunities
Net debt to EBITDA of 0.59x is manageable, giving SNWV more balance-sheet room than highly levered peers if operating conditions improve.
Days payables outstanding of 111 provide supplier-funding support, which can partially offset inventory intensity better than peers with shorter payment terms.
If inventory normalizes from 237 days, cash release could improve liquidity and reduce financing needs more visibly than in faster-turning peer models.
Overall Score
SNWV faces meaningful leverage, weak interest coverage, and slow working-capital turnover versus peers, while modest net debt and supplier financing provide some offsetting flexibility.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on SANUWAVE Health Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
